Envoy Medical, Inc. (COCHW) stock
COCHWNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as COCH
$0.03−0.00 (-15.49%)
Close on Oct 30, 2026Market cap $511.80MP/E –Yield –
Envoy Medical free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Envoy Medical's free cash flow for the twelve months ending Dec 31, 2025 was -$18.38M. For fiscal 2025 it was -$18.38M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$18.38M | – |
| FY2024 | Dec 31, 2024 | -$18.93M | – |
| FY2023 | Dec 31, 2023 | -$17.24M | – |
| FY2022 | Dec 31, 2022 | -$9.02M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -$5.86M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.33M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.46M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.73M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.56M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.78M | -464.5% |
| Q2 FY2024 | Jun 30, 2024 | -$4.89M | – |
| Q1 FY2024 | Mar 31, 2024 | -$5.70M | – |
| Q4 FY2023 | Dec 31, 2023 | -$11.17M | – |
| Q3 FY2023 | Sep 30, 2023 | $1.04M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.05M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.07M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.42M | – |